MiR-27a is up regulated and promotes inflammatory response in sepsis

Cellular Immunology

Volumn 290, Issue 2, 2014, Pages 190-195

  Wang, Zhongchuan ^a   Ruan, Zhengshang ^a   Mao, Yanfei ^a   Dong, Wenwen ^a   Zhang, Yunqian ^a   Yin, Na ^a   Jiang, Lai ^a  

^a XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

IL 6; Inflammatory response; MiR 27a; NF B p65; Sepsis; TNF

Indexed keywords

INTERLEUKIN 6; MICRORNA; MICRORNA 129 5P; MICRORNA 143; MICRORNA 153; MICRORNA 218; MICRORNA 27A; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MIRN27 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; IN VIVO STUDY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS; UPREGULATION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DISEASE MODEL; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; INFLAMMATION; METABOLISM; PATHOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SEPSIS; UP-REGULATION;

EID: 84904459461     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.06.006     Document Type: Article

References (22)

1. Gutierrez S.M., et al. Candidemia in ICU patients with sepsis. Crit. Care Med. 2013, 41(11):e385.
2. Panagiotou A., Gaiao S., Cruz D.N. Extracorporeal therapies in sepsis. J. Intensive Care Med. 2013, 28(5):281-295.
3. Huang Z., et al. Effect on extrapulmonary sepsis-induced acute lung injury by hemoperfusion with neutral microporous resin column. Ther. Apher. Dial. 2013, 17(4):454-461.
4. Li H., et al. NF-kappaB inhibition after cecal ligation and puncture reduces sepsis-associated lung injury without altering bacterial host defense. Mediators Inflamm. 2013, 2013:503213.
5. Zhu T., et al. Andrographolide protects against LPS-induced acute lung injury by inactivation of NF-kappaB. PLoS One 2013, 8(2):e56407.
6. Meyer C., et al. Transcript and protein profiling identifies signaling, growth arrest, apoptosis, and NF-kappaB survival signatures following GNRH receptor activation. Endocr. Relat. Cancer 2013, 20(1):123-136.
7. Zhang X.Y., Chen L.H., Guan Y.F. PPAR family and its relationship to metabolic syndrome. Sheng Li Ke Xue Jin Zhan 2005, 36(1):6-12.
8. Kamon J., Yamauchi T., Kadowaki T. PPAR family (PPAR alpha, PPAR delta, PPAR gamma). Nihon Rinsho 2002, 60(Suppl. 7):593-600.
9. Wahli W. A gut feeling of the PXR, PPAR and NF-kappaB connection. J. Intern. Med. 2008, 263(6):613-619.
10. Vanden Berghe W., et al. A paradigm for gene regulation: inflammation, NF-kappaB and PPAR. Adv. Exp. Med. Biol. 2003, 544:181-196.
11. Wang Y., Li X., Hu H. Transcriptional regulation of co-expressed microRNA target genes. Genomics 2011, 98(6):445-452.
12. Remick D.G., et al. Comparison of the mortality and inflammatory response of two models of sepsis: lipopolysaccharide vs. cecal ligation and puncture. Shock 2000, 13(2):110-116.
13. Lin M.S., et al. Expression of PPARgamma and PTEN in human colorectal cancer: an immunohistochemical study using tissue microarray methodology. Oncol. Lett. 2011, 2(6):1219-1224.
14. Kitamura Y., et al. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice. Am. J. Respir. Crit. Care Med. 2001, 163(3 Pt 1):762-769.
15. Pulli B., et al. Measuring myeloperoxidase activity in biological samples. PLoS One 2013, 8(7):e67976.
16. Jimenez-Mateos E.M., et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat. Med. 2012, 18(7):1087-1094.
17. Kim S.Y., et al. miR-27a is a negative regulator of adipocyte differentiation via suppressing PPARgamma expression. Biochem. Biophys. Res. Commun. 2010, 392(3):323-328.
18. Whalan C., Drew P., Maddern G. Infection, sepsis and systemic inflammatory response syndrome in obstructive jaundice. J. Gastroenterol. Hepatol. 1998, 13(4):354-355.
19. Furian T., et al. Ventricular dysfunction and dilation in severe sepsis and septic shock: relation to endothelial function and mortality. J. Crit. Care 2012, 27(3):319. (e9-15).
20. Bickler S.W., De Maio A. Dysfunction of the innate immune system during sepsis: a call for research. Crit. Care Med. 2013, 41(1):364-365.
21. Jiang C., Ting A.T., Seed B. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature 1998, 391(6662):82-86.
22. Chawla A. Control of macrophage activation and function by PPARs. Circ. Res. 2010, 106(10):1559-1569.